Abstract:Background Herpes simplex virus type 1 (HSV-1) is a ubiquitous infectious pathogen that widely affects human health. To decipher the complicated human-HSV-1 interactions, a comprehensive protein-protein interaction (PPI) network between human and HSV-1 is highly demanded. Methods To complement the experimental identification of human-HSV-1 PPIs, an integrative strategy to predict proteome-wide PPIs between human and HSV-1 was developed. For each human-HSV-1 protein pair, four popular PPI inference methods, including interolog mapping, the domain-domain interaction-based method, the domain-motif interaction-based method, and the machine learning-based method, were optimally implemented to generate four interaction probability scores, which were further integrated into a final probability score. Results As a result, a comprehensive high-confidence PPI network between human and HSV-1 was established, covering 10,432 interactions between 4,546 human proteins and 72 HSV-1 proteins. Functional and network analyses of the HSV-1 targeting proteins in the context of human interactome can recapitulate the known knowledge regarding the HSV-1 replication cycle, supporting the overall reliability of the predicted PPI network. Considering that HSV-1 infections are implicated in encephalitis and neurodegenerative diseases, we focused on exploring the biological significance of the brain-specific human-HSV-1 PPIs. In particular, the predicted interactions between HSV-1 proteins and Alzheimer’s-disease-related proteins were intensively investigated. Conclusion The current work can provide testable hypotheses to assist in the mechanistic understanding of the human-HSV-1 relationship and the anti-HSV-1 pharmaceutical target discovery. To make the predicted PPI network and the datasets freely accessible to the scientific community, a user-friendly database browser was released at http://www.zzdlab.com/HintHSV/index.php .

Receptors and ligands for herpes simplex viruses: Novel insights for drug targeting

[Mechanisms of Herpes Simplex Virus Latency and Reactivation].

Prediction and Analysis of Human-Herpes Simplex Virus Type 1 Protein-Protein Interactions by Integrating Multiple Methods

Role of dendritic cells in host immunity to herpes simplex virus and possible mechanisms

Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents

Ligands and receptors in human cytomegalovirus entry: Current therapies and new directions

Toll‐like Receptors As Novel Therapeutic Targets for Herpes Simplex Virus Infection

Herpes Simplex Virus Cell Entry Mechanisms: An Update

Insight into structural properties of viral G protein‐coupled receptors and their role in the viral infection: IUPHAR Review 41

Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection

A review of HSV pathogenesis, vaccine development, and advanced applications

Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D

The structural basis of herpesvirus entry

A review: Natural polysaccharides from medicinal plants and microorganisms and their anti-herpetic mechanism

Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B

[New drug targets of herpesviruses]

Anti-herpes simplex virus activities and mechanisms of marine derived compounds

Immunological Identification and Characterization of the Capsid Scaffold Protein Encoded by UL26.5 of Herpes Simplex Virus Type 2

An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application

Nectin-1 and Non-muscle Myosin Heavy Chain-IIB: Major Mediators of Herpes Simplex Virus-1 Entry into Corneal Nerves.

Archaic connectivity between the sulfated heparan sulfate and the herpesviruses - An evolutionary potential for cross-species interactions